Free Trial
LON:CIZ

Cizzle Biotechnology (CIZ) Share Price, News & Analysis

GBX 1.60
+0.05 (+3.23%)
(As of 09/6/2024 ET)
Today's Range
1.50
1.68
50-Day Range
1.52
2.23
52-Week Range
1.42
3.38
Volume
968,365 shs
Average Volume
1.37 million shs
Market Capitalization
£6.34 million
Assets Under Management
£48.98 million
Dividend Yield
3.45%
Net Expense Ratio
0.46%
CIZ stock logo

About Cizzle Biotechnology (LON:CIZ)

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

CIZ Stock Price History

CIZ ETF News Headlines

Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings Plc (CIZ.L)
Biden's Successor: The Radical Threat to YOUR Savings!
Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.
Philadelphia Biotech News
Cizzle Biotechnology Holdings PLC (CIZ)
Biden's Successor: The Radical Threat to YOUR Savings!
Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.
See More Headlines
Receive CIZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Victory Capital Management
Fund Name
VictoryShares Developed Enhanced Volatility Wtd ETF
Tax Classification
Regulated Investment Company
Inception Date
9/30/2014
Fund Manager
Mannik Dhillon, Stephen Hammers

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index
Category
Size and Style
Focus
Large Cap
Development Level
Developed Markets
Region
Global Ex-U.S.
Number of Holdings
505

Fund Statistics

Assets Under Management
$48.98 million
Average Daily Volume
$9,243.20
Discount/Premium
0.17%

Administrator, Advisor and Custodian

Administrator
Victory Capital Management Inc.
Advisor
Victory Capital Management Inc.
Custodian
Citibank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Options

Optionable
N/A
Short Interest
15,600 shs

Miscellaneous

Beta
0.36
Creation Unit
50,000
Creation Fee
$4,500.00
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Cizzle Biotechnology Expenses

TypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFs
Management Fee0.40%0.57%0.55%0.45%0.52%
Other Expenses0.25%0.30%0.49%0.25%0.54%
Total Expense0.66%0.64%0.71%0.54%0.71%
Fee Waiver-0.20%-0.25%-0.53%-0.20%-0.58%
Net Expense0.46%0.61%0.61%0.47%0.59%

Cizzle Biotechnology (CIZ) Holdings & Exposure

Top 10 CIZ Holdings

  • Koninklijke KPN NV
    Holding Weight: 0.46%
  • London Stock Exchange Group plc
    Holding Weight: 0.41%
  • Deutsche Telekom AG
    Holding Weight: 0.40%
  • Unilever PLC
    Holding Weight: 0.39%
  • Oversea-Chinese Banking Corporation Limited
    Holding Weight: 0.38%
  • Zurich Insurance Group AG
    Holding Weight: 0.38%
  • DBS Group Holdings Ltd
    Holding Weight: 0.37%
  • Generali
    Holding Weight: 0.36%
  • Royal Bank of Canada
    Holding Weight: 0.36%
  • Commonwealth Bank of Australia
    Holding Weight: 0.35%

CIZ Sector Exposure

CIZ Industry Exposure

Key Executives

  • Mr. Allan John Syms (Age 68)
    Executive Chairman
  • Prof. Dawn Coverley (Age 59)
    Founder, Chief Scientific Officer & Non-Executive Director
  • Mr. Nigel R. Lee (Age 63)
    Finance Director & Executive Director
  • Mr. Morgan Williams
    Head of Commercialisation for Yorkshire Cancer Research and Board Observer

CIZ ETF - Frequently Asked Questions

How have CIZ shares performed this year?

Cizzle Biotechnology's stock was trading at GBX 1.95 on January 1st, 2024. Since then, CIZ shares have decreased by 17.9% and is now trading at GBX 1.60.
View the best growth stocks for 2024 here
.

How do I buy shares of Cizzle Biotechnology?

Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CIZ) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners